Entrada said Thursday that Cohort 1 demonstrated an increase of 2.36% in dystrophin over a baseline of 4% and an increase of 2.31% in exon skipping over a baseline of 2.66% in treated participants.
Many patients with vitiligo remain untreated, and those who are treated receive short, variable therapies, researchers report.
Objective Strategies to Embrace Living with Lupus Fearlessly (SELF) is an online self-management education programme for ...
This retrospective, single‐center study included all patients aged 18 to 65 years who presented with ACS and underwent ...
Objectives We explored whether a spike in running distance during a single session or over 1 week, compared with the preceding period, was associated with increased risk of running-related overuse ...
Objective The objective is to determine the association and absolute risk of femoroacetabular impingement syndrome (FAIS) for the development of radiographic hip osteoarthritis (RHOA). Methods This is ...